Q: Hello 5i
I have owned RGEN for several years.
Could you tell me how you would rank it against its peers? Is there a name you prefer more and if so why?
Thank you so much!!
Dave
Will Zimmer spin off have positive effect on its share price and future growth? If you must choose 1 of the 2, would you choose Zim Vie over Zimmer Biomet?
Q: I'm trying to understand NBLY .... For starters it is a chain of drug stores that is losing money ... Why ? ..... And second what is the hook here ? I understand the format of Shoppers ..... Flyers, weekly sales, and appear to be a grocery and makeup store more than a pharmacy . What is the format in a Neighbourly Pharmacy when one enters the door ? Is it a pure pharmacy ? ...... Are there other products sold ? .....What does the corporate structure offer to these places ? What is your opinion on management ? ......Please explain what the attraction is here ? Thanks Garth
Q: I currently hold Abbvie and PFE in our portfolio. I'm looking to add another in the healthcare sector, such as Eli Lily, Merck or Danaher. Do you have a preference among thee to add or another?
Q: I own both BMY and GILD, both of which have not done much the past few years except provide a stable dividend. I have enough health and death care ( - PLC:) ) stocks currently and would be OK to sell or raise some cash.
Do you think one or both of these have an upgraded outlook and are worth holding for the next year or two?
Thank you for the great service.
Q: I previously asked you about MDT (November 3, 2021). You suggested to wait till January 2022. My original question has specifics including asking you to confirm certain key ratios. Kindly update your answer, especially in view of yesterday’s positive article on MDT. MDT and other medical equipment businesses have been stumbling due to Covid. I especially like MDT products in my med work, but that of course is not enough reason to buy.
Kindly confirm what you see on Bloomberg for the following:
PEG
FWD P/E
ROE and ROCI
Do you think the value for EV/FCF makes MDT a decent buy today?
Doing some due diligence on DOC. Can you help me understand a few things?
1) Views on recent acquisition(s) and how they fit into DOC's operating model?
2) Can you dig into their fundamentals and explain current state?
When do they report next, and are there any estimates? I don't see much in the way of analyst coverage.
Q: I think this bio tech etc has recently had a tough time. I know that you recommend it. But,I was wondering whether you think this might be it's time to recuperate it's losses? Do you have something that you like more than this. If so, why? As always thanks for the great service
Q: There has been some recent news indicating a positive outlook for Halozyme Therapeutics future earnings. Please provide 5i's perspective.
Thank you, Patrick
Q: Good morning everyone at 5i
I have been thinking of selling gild at a tax loss following their earnings report. Wondering what you would see as a replacement in order to buy back later. And should I buy back later or just keep the replacement. I already own abbievie in this sector.
Q: CSTL has doubled their sales force, advanced commercialization of its flagship DecisionDx-Melanoma test, and they acquired Cernostics - an early-stage diagnostic company, plus they have $300 mil in cash. The stock price is off 70% on a company that looks to have sold fundamentals. Could I have your assessment of this being a buy scenario?
Q: You last took a look at this one 5 months ago, and thought at those levels, it could look potentially interesting. Given the shift in market sentiment since then, how do you feel about this now? Far, far less interested?
Thank you as always...
My portfolio is currently underweight in healthcare and I am looking to add either ZUH or XHC. My goal is long-term growth rather than income, so I think either of these would be a better fit than HHL or LIFE. Looking through past questions, it seems that your preference has been for XHC due to its greater diversification, global exposure, and better valuations of its underlying holdings.
I was wondering if you would still prefer XHC over ZUH? Or has the current pullback done anything to alter your view on these ETFs?
Thank you for thoughts and for the excellent service.
Q: Want to trade JNJ out of my US dividend growth portfolio (retired, live on divys) as to not be in a complicated tax situation when the company splits up. What is a good trade for JNJ? Dividend amount and growth is important. Thanks Ron